Amelogenin antigenic domain defined by clonal epitope selection

Dental fluorosis: chemistry and biology

This review aims at discussing the pathogenesis of enamel fluorosis in relation to a putative linkage among ameloblastic activities, secreted enamel matrix proteins and multiple proteases, growing enamel crystals, and fluid composition, including calcium and fluoride ions. Fluoride is the most important caries-preventive agent in dentistry. In the last two decades, increasing fluoride exposure in various forms and vehicles is most likely the explanation for an increase in the prevalence of mild-to-moderate forms of dental fluorosis in many communities, not the least in those in which controlled water fluoridation has been established. The effects of fluoride on enamel formation causing dental fluorosis in man are cumulative, rather than requiring a specific threshold dose, depending on the total fluoride intake from all sources and the duration of fluoride exposure. Enamel mineralization is highly sensitive to free fluoride ions, which uniquely promote the hydrolysis of acidic precursors such as octacalcium phosphate and precipitation of fluoridated apatite crystals. Once fluoride is incorporated into enamel crystals, the ion likely affects the subsequent mineralization process by reducing the solubility of the mineral and thereby modulating the ionic composition in the fluid surrounding the mineral. In the light of evidence obtained in human and animal studies, it is now most likely that enamel hypomineralization in fluorotic teeth is due predominantly to the aberrant effects of excess fluoride on the rates at which matrix proteins break down and/or the rates at which the by-products from this degradation are withdrawn from the maturing enamel. Any interference with enamel matrix removal could yield retarding effects on the accompanying crystal growth through the maturation stages, resulting in different magnitudes of enamel porosity at the time of tooth eruption. Currently, there is no direct proof that fluoride at micromolar levels affects proliferation and differentiation of enamel organ cells. Fluoride does not seem to affect the production and secretion of enamel matrix proteins and proteases within the dose range causing dental fluorosis in man. Most likely, the fluoride uptake interferes, indirectly, with the protease activities by decreasing free Ca(2+) concentration in the mineralizing milieu. The Ca(2+)-mediated regulation of protease activities is consistent with the in situ observations that (a) enzymatic cleavages of the amelogenins take place only at slow rates through the secretory phase with the limited calcium transport and that, (b) under normal amelogenesis, the amelogenin degradation appears to be accelerated during the transitional and early maturation stages with the increased calcium transport. Since the predominant cariostatic effect of fluoride is not due to its uptake by the enamel during tooth development, it is possible to obtain extensive caries reduction without a concomitant risk of dental fluorosis. Further efforts and research are needed to settle the currently uncertain issues, e.g., the incidence, prevalence, and causes of dental or skeletal fluorosis in relation to all sources of fluoride and the appropriate dose levels and timing of fluoride exposure for prevention and control of dental fluorosis and caries.

Alternative splicing of the mouse amelogenin primary RNA transcript contributes to amelogenin heterogeneity

A heterogeneous population of amelogenin proteins is derived from a single copy of the mouse amelogenin gene. To investigate the one gene--multiple protein enigma, we designed a study to distinguish between alternative splicing and proteolytic cleavage models. A pulse of [35S]methionine labeling demonstrated that multiple amelogenins are synthesized concurrently, a result consistent with an alternative splicing mechanism. Using reverse transcription and polymerase chain reaction we cloned a segment from the 5' end of a mouse amelogenin mRNA and connected it to a previously isolated abbreviated cDNA clone. Four additional cDNAs derived from alternatively spliced amelogenin mRNAs have been cloned and characterized. The five transcripts encode amelogenins 180, 156, 141, 74, and 59 amino acids in length.

Common epitopes of mammalian amelogenins at the C-terminus and possible functional roles of the corresponding domain in enamel mineralization

The present studies were undertaken to investigate the presence of common epitopes of mammalian amelogenins at the C-terminus and the possible functional importance of the conserved C-terminal domain in enamel mineralization during mammalian amelogenesis. Enamel proteins, including the intact amelogenins and their degraded polypeptides, were isolated from the secretory enamel of pig, cow, rat, and rabbit incisors. Rabbit and rat antipeptide sera, as well as rat anti-25 kD and 20 kD pig amelogenin sera, were used to identify the amelogenins among the isolated matrix proteins of each of the animal species. The antipeptide sera were developed previously (Aoba et al. [19]) using as immunogens the two synthetic peptides, C13 and C25, which correspond to the last 12 (plus Cys for KLH-conjugation) and 25 amino acid residues of pig intact amelogenin, respectively. Reactivity of the enamel proteins with each antiserum was examined by Western blot analysis. The results of immunoblotting showed that a few enamel matrix proteins in each of the mammalian species were recognized by the anti-C13 serum, specifically, pig amelogenin at 25 kD (and trace components at 27, 22, and 18 kD), cow amelogenin at 28 kD (trace components at 26, 22, 19, and 14 kD), rat amelogenins at 28 and 26 kD (and a trace component at 20 kD), and rabbit amelogenins at 24 and 21 kD (and a trace at 13 kD). The anti-C25 serum reacted additionally with pig amelogenin at 23 kD, cow amelogenin at 27 kD (a major matrix constituent), and rabbit protein at 19 kD.(ABSTRACT TRUNCATED AT 250 WORDS)

Anti-peptide antibodies reactive with epitopic domains of porcine amelogenins at the C-terminus

This was an immunological investigation of the processing of porcine amelogenins in situ. Rabbit and rat anti-peptide sera reacted specifically with the hydrophilic segment of the intact amelogenins at the C-terminus. The immunogens used were the synthetic peptides: (a) C13 composed of PATDKTKREEVDC and (b) C25 composed of MQSLLPDLPLEAWPATDKTKREEVD. These peptides correspond to the C-terminal 12- and 25-residue segments of porcine amelogenin, respectively. Cystine was introduced at the C-terminus of C12 for KLH-binding (C13). Western blot analysis disclosed that: (i) both rabbit and rat anti-C13 sera reacted selectively with the 25-kDa porcine amelogenin and three other minor components (27, 22 and 18 kDa); (ii) anti-C25 peptide sera, additionally, reacted with the 23-kDa amelogenins (a degradation derivative of the 25-kDa protein, lacking the 12-residue segment at the C-terminus) and as trace components, 20-, 16- and 14-kDa moieties. Importantly, all the proteins reactive with the anti-C13 serum were concentrated in the outer secretory enamel adjacent to the ameloblasts, decreasing significantly in the underlying inner secretory enamel. Immunohistochemical studies applying the anti-peptide sera to the developing tooth germs of a minipig also confirmed the localization of reactivity in the outer secretory region. Neither anti-peptide serum reacted with porcine non-amelogenins, serum proteins nor dentine matrix proteins at the dilutions tested. however, it was found that both the anti-C13 and C25 sera reacted with human keratin.(ABSTRACT TRUNCATED AT 250 WORDS)

Biochemical characterization of stable high molecular-weight aggregates of amelogenins formed during porcine enamel development

Analysis of the enamel matrix during porcine tooth formation has revealed a number of high molecular-weight (Mr) enamel proteins (greater than 30 kDa), which are related to the major amelogenins (20-26 kDa). To examine the nature of these proteins, amelogenins were extracted and separated by conventional gel filtration and reverse phase HPLC. Many of the proteins in the high Mr fraction reacted with a polyclonal antibody, affinity-purified against a mixture of 20-26 kDa amelogenins. Another antibody, affinity-purified against a fraction containing the LRAP, reacted with amelogenins 30-36 kDa in size but not with amelogenins 40 kDa or larger, indicating that the high Mr amelogenins were a heterogeneous group of enamel proteins. Analysis of amino acid composition and N-terminal amino acid sequence, as well as PASGE of electrophoretically eluted proteins, indicated that the high Mr amelogenins were aggregates of various major amelogenins. Three amelogenin aggregates (43, 40 and 32 kDa) isolated by electrophoretic elution were less stable at 100 degrees C in SDS-containing buffer than at 60 degrees C. In contrast to the major amelogenins, which are found in constant proportions throughout enamel development, the high Mr amelogenins appeared to increase in maturing enamel relative to the total matrix protein. Thus, at least in the pig high Mr amelogenins appear to be naturally occurring, stable aggregates of major amelogenins. It is proposed that amelogenin aggregation occurs as a consequence of the diminishing spaces between growing crystals in maturing enamel.

Splice of life: toward understanding genetic determinants of oral diseases

The introduction of recombinant DNA technology has led to a rapid advancement of our knowledge of genes and genomic structure. Such technology, applied to the human genome, has provided valuable information concerning the nature and possible treatment of inherited disorders throughout the human life span. A number of oral diseases can be attacked by use of molecular biological techniques in conjunction with genetic linkage analysis. It will be possible to identify carriers of inherited diseases, to utilize prenatal and antenatal diagnosis when appropriate, and to pursue studies on the mode of inheritance of specific oral diseases. Present and projected advances in this dimension of dental research provide the knowledge and strategies for approaching and solving a number of major problems as we continue to pave the way for improvements in the diagnosis, treatment, and prevention of many oral and craniofacial diseases. This position paper examines a few of the promising areas and suggests future goals toward establishing a knowledge of the genetic determinants for oral diseases.

1987 Kreshover lecture. Gene regulation in the development of oral tissues

The regulatory processes associated with tooth formation are being investigated by the identification of when, where, and how cell adhesion molecules (CAMs), substrate adhesion molecules (SAMs), dentin phosphoprotein, enamel gene products, and intermediate cementum products are expressed during sequential developmental stages of morphogenesis, cytodifferentiation, dentin, enamel and cementum extracellular matrix (ECM) formation, and biomineralization. Instructive and permissive signaling is required for both morphogenesis and cytodifferentiation based upon in vitro organotypic culture studies in serumless, chemically-defined medium. Intrinsic developmental instructions, independent of exogenous growth factors, mediate tooth morphogenesis from the initiation of the dental lamina through crown and initial root development. Recent progress using recombinant DNA methods has advanced descriptions of several dental structural genes. The complete nucleic acid sequence for mouse amelogenin has been defined. This sequence is located on the mouse X chromosome and on the human X and Y chromosomes. This discussion summarizes recent results using experimental embryology, recombinant DNA technology, and immunocytology in the context of instructive epithelial-mesenchymal interactions associated with epithelial differentiation into ameloblasts, ectomesenchyme differentiation into odontoblasts, and dentin and enamel ECM biomineralization. The tooth organ provides opportunities at several levels of biological organization to investigate cellular, molecular, and developmental processes.

Examining the possible molecular origins for enamel protein complexity

Our strategy was to examine each of the three loci capable of contributing to the observed complexity 0 of mouse amelogenin proteins recovered from forming enamel: the genome (gene); the transcription apparatus (messenger RNA); and the translation apparatus (proteins). Our approach was based on recombinant DNA technology and a complementary DNA (cDNA) clone, pMa5-5, specific to the predominant mouse amelogenin protein. An "artificial ameloblast" was engineered based on pMa5-5 and the resulting synthetic products compared to those from authentic ameloblasts. First, the genome probably is not responsible for amelogenin complexity: Southern analysis indicates that the amelogenin gene exists as a single copy in either differentiated dental tissue or germ line tissue. Thus, ectomesenchymal-derived instructive signals for ameloblast differentiation do not lead to re-arrangement or amplification of the amelogenin gene. Next, using nucleic acid hybridization techniques, we examined messenger RNA from mouse ameloblasts. Northern analysis of authentic mRNA from mouse ameloblasts, with either the intact or 3'-end of pMa 5-5 used as the reporter molecule, indicates that only one size class of mRNA was detectable. We conclude that at the sensitivity of this assay there is no evidence for multiple mRNAs. Last, "artificial ameloblasts" were engineered so that the translation apparatus could be examined as a source of amelogenin complexity. Capped, artificial mRNAs were constructed to the pMa 5-5 template and used to program the synthesis of amelogenin polypeptides by translation in a cell-free system. When the resulting total translation products were immunoprecipitated with the rabbit anti-mouse amelogenin antibody, we observed multiple polypeptides, suggesting that the utilization of alternative start sites may also contribute to the observed complexity of amelogenin proteins, at least for artificial mRNAs translated in vitro.